<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> ischaemic left ventricular dysfunction, revascularization may lead to symptomatic and prognostic improvement </plain></SENT>
<SENT sid="1" pm="."><plain>Cardiovascular magnetic resonance (CMR) imaging with its high spatial resolution provides the qualitative and quantitative, global and regional information on myocardial <z:mp ids='MP_0000002'>anatomy</z:mp> and function </plain></SENT>
<SENT sid="2" pm="."><plain>In combination with a <z:chebi fb="0" ids="33375">gadolinium</z:chebi>-based contrast agent, CMR allows an accurate quantification of the myocardial scar and predicts the likelihood of functional recovery after revascularization </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this review is to summarize our current understanding of the detection of myocardial viability using CMR, and why it may be the preferred technique in the assessment of patients with ischaemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
</text></document>